Search Results 191-200 of 11435 for ���������������������������:za33���24������ ������������������������ ������
... 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma.
Rochester, Minnesota: 24-010877. NCT ID: NCT06873802. Sponsor Protocol Number: 24-010877. About this study. The purpose of this study is to demonstrate that ZTE ...
The purpose of this study is to evaluate the effectiveness, safety, tolerability, and PK of INCB000928 over a 24-week treatment period followed by a 52-week ...
... 24 months. History of untreated celiac disease or gluten enteropathy. Patients with an absolute neutrophil count < 500 cells/mm3. Participating Mayo Clinic ...
Jacksonville, Florida: 24-009952; Rochester, Minnesota: 24-009952; Scottsdale/Phoenix, Arizona: 24-009952. NCT ID: NCT06395519. Sponsor Protocol Number: ETX ...
Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients ...
The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...
... 24 months; Have a sinus CT scan within the past 24 months with a Lund-Mackay score >5; Nasal polyps must be documented within the past 3 years on physical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.